Skip to Main Content
 

Global Search Box

 
 
 
 

Files

File List


kelsey craig thesis 4.20.18 copy .pdf (3.45 MB)

ETD Abstract Container

Abstract Header

A Novel Lactic Acid Bacteria (LAB)-based Vaccine Candidate for Human Norovirus

Craig, Kelsey L, Craig
http://rave.ohiolink.edu/etdc/view?acc_num=osu1524170939202923

Abstract Details

2018, Master of Science, Ohio State University, Comparative and Veterinary Medicine.
Human noroviruses (HuNoVs) are responsible for more than 95% of the non-bacterial acute gastroenteritis epidemics in the world. The CDC estimates that every year 21 million individuals suffer from HuNoV-induced gastroenteritis in the U.S. Currently, there is no FDA-approved vaccine for HuNoVs. Development of an effective vaccine has been seriously hampered by the lack of an efficient cell culture system for HuNoVs and a suitable small animal model. The goal of this study is to develop lactic acid bacteria (LAB) as a vector to deliver HuNoV antigen. To do this, a LAB bacteria strain (Lactococcus lactis) carrying VP1 gene of a HuNoV GII.4 virus (LAB-VP1) was constructed. It was found that HuNoV VP1 protein was highly expressed by LAB vector. Subsequently, a novel microencapsulation technology was developed to enhance the stability of LABs in low and high pH environments. To test whether LAB-based HuNoV vaccine is immunogenic, 4-day-old gnotobiotic piglets were orally inoculated with various doses of LAB-VP1 either with or without microencapsulation. It was found that LABs were persistent in the small intestine of piglets and shed in pig feces for at least 25 days post inoculation. Live LABs or LAB DNA were found in mesenteric lymph nodes and spleen tissue in LAB-VP1 inoculated groups. HuNoV-specific IgG and IgA were detectable in serum and feces at day 13 post-inoculation, respectively, and further increased at late time points. After challenge with HuNoV GII.4 strain, a large amount of HuNoV antigens were observed in the duodenum, jejunum, and ileum sections of the intestine in the LAB control group. In contrast, significantly less or no HuNoV antigens were detected in the LAB-VP1 immunized groups. Collectively, these results demonstrate that LAB-based HuNoV vaccine induces protective immunity in gnotobiotic piglets.
Jianrong Li (Advisor)
Prosper Boyaka (Committee Member)
Melvin Pascall (Committee Member)
147 p.
Microbiology; Virology
vectored vaccine; gnotobiotic pig model; lactococcus lactis; lactic acid bacteria; human norovirus

Recommended Citations

Citations

  • Craig, Craig, K. L. (2018). A Novel Lactic Acid Bacteria (LAB)-based Vaccine Candidate for Human Norovirus [Master's thesis, Ohio State University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=osu1524170939202923

    APA Style (7th edition)

  • Craig, Craig, Kelsey. A Novel Lactic Acid Bacteria (LAB)-based Vaccine Candidate for Human Norovirus . 2018. Ohio State University, Master's thesis. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=osu1524170939202923.

    MLA Style (8th edition)

  • Craig, Craig, Kelsey. "A Novel Lactic Acid Bacteria (LAB)-based Vaccine Candidate for Human Norovirus ." Master's thesis, Ohio State University, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=osu1524170939202923

    Chicago Manual of Style (17th edition)

osu1524170939202923
350
© 2018, all rights reserved.
This open access ETD is published by The Ohio State University and OhioLINK.